Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model

被引:70
作者
Henderson, WR
Lu, JY
Poole, KM
Dietsch, GN
Chi, EY
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] ICOS Corp, Bothell, WA 98021 USA
关键词
D O I
10.4049/jimmunol.164.6.3360
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous in vitro and in vivo studies in both animal models and human asthmatics have implicated platelet-activating factor (PAF) as an important inflammatory mediator in asthma, In a murine asthma model, we examined the anti-inflammatory activities of recombinant human PAF-acetylhydrolase (rPAF-AH), which converts PAF to biologically inactive lyso-PAF. In this model mice sensitized to OVA by i.p, and intranasal (i.n.) routes are challenged with the allergen by i,n, administration, The OVA challenge elicits an eosinophil infiltration into the lungs with widespread mucus occlusion of the airways and results In bronchial hyperreactivity, The administration of rPAF-AH had a marked effect on late-phase pulmonary inflammation, which included a significant reduction in airway eosinophil infiltration, mucus hypersecretion, and airway hyperreactivity in response to methacholine challenge. These studies demonstrate that elevating plasma levels of PAF-AH through the administration of rPAF-AH is effective in blocking the late-phase pulmonary inflammation that occurs in this murine allergen-challenge asthma model. These results suggest that rPAF-AH may have therapeutic effects in patients with allergic: airway inflammation.
引用
收藏
页码:3360 / 3367
页数:8
相关论文
共 64 条
[1]   PLATELET-ACTIVATING-FACTOR STIMULATES SECRETION OF MUCIN BY EXPLANTS OF RODENT AIRWAYS IN ORGAN-CULTURE [J].
ADLER, KB ;
SCHWARZ, JE ;
ANDERSON, WH ;
WELTON, AF .
EXPERIMENTAL LUNG RESEARCH, 1987, 13 (01) :25-43
[2]   MECHANICS OF RESPIRATION IN UNANESTHETIZED GUINEA PIGS [J].
AMDUR, MO ;
MEAD, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1958, 192 (02) :364-368
[3]  
AUBAS P, 1984, AM REV RESPIR DIS, V130, P875
[4]  
CAMUSSI G, 1983, AM J PATHOL, V112, P78
[5]  
CARLOS TM, 1994, BLOOD, V84, P2068
[6]   THE RELEASE OF PLATELET-ACTIVATING-FACTOR INTO PLASMA DURING ALLERGEN-INDUCED BRONCHOCONSTRICTION [J].
CHANYEUNG, M ;
LAM, S ;
CHAN, H ;
TSE, KS ;
SALARI, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 87 (03) :667-673
[7]  
CHRISTMAN BW, 1987, AM REV RESPIR DIS, V135, P1267
[8]   EFFECTS OF PLATELET ACTIVATING FACTOR ON AIRWAY CALIBER, AIRWAY RESPONSIVENESS, AND CIRCULATING CELLS IN ASTHMATIC SUBJECTS [J].
CHUNG, KF ;
BARNES, PJ .
THORAX, 1989, 44 (02) :108-115
[9]  
CHUNG KF, 1986, J PHARMACOL EXP THER, V236, P580
[10]   Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge [J].
Chvatchko, Y ;
KoscoVilbois, MH ;
Herren, S ;
Lefort, J ;
Bonnefoy, JY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2353-2360